INVIVO THERAPEUTICS HOLDINGS CORP.·4

Jun 21, 4:06 PM ET

Toselli Richard M. 4

4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Jun 21, 2019

Insider Transaction Report

Form 4
Period: 2019-06-19
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-06-19$0.75/sh72$5410,543 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,228
Footnotes (2)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligationsapplicable to the vesting of 250 stock-settled RSUs.
  • [F2]Between January 1, 2018 and June 20, 2019, the reporting person acquired 5,228 shares of NVIV common stock under the NVIV 401(k) plan. The information in this report is based on a plan statement dated as of June 20, 2019.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -